Transfusion Guidelines for Severe Anemia and Thrombocytopenia

Introduction to Transfusion Priorities

The American College of Physicians recommends that patients with hemoglobin levels below 7 g/dL should receive transfusions, as this threshold is associated with increased risk of adverse outcomes 1, 2, 3
Patients with platelet counts of 15,000/μL are at significant risk for spontaneous bleeding, and prophylactic platelet transfusion is recommended for hospitalized patients with therapy-induced thrombocytopenia 4

The American Society of Hematology suggests that the order of transfusion matters less than the speed of administration, and both products should be given promptly 4, 5
One unit of PRBCs typically increases hemoglobin by approximately 1 g/dL, and transfusion should be done slowly in single units with clinical reassessment between units to avoid volume overload 3, 5
Platelet transfusion should follow immediately or be given concurrently if two IV access sites are available, with a target post-transfusion platelet count >50,000/μL if any procedures are planned 4, 6

The risk of transfusion-associated circulatory overload (TACO) increases with rapid transfusion, and monitoring for tachypnea, dyspnea, and signs of pulmonary edema during transfusion is essential 2, 3
Spontaneous bleeding risk increases significantly below 10,000/μL, and any invasive procedure requires platelet transfusion with a target count >20,000/μL for central line placement and >50,000/μL for lumbar puncture 4, 6

The American College of Critical Care Medicine recommends a restrictive transfusion strategy (7-8 g/dL) for most patients, and guidelines for massive transfusion protocols suggest fixed ratios (1:1:1 of plasma:platelets:PRBCs) without specifying strict sequence requirements 2, 7
The American Society of Clinical Oncology suggests that patients with platelet disorders and concomitant anemia have worse bleeding outcomes, and correction of anemia leads to clinical improvement 9